Send me a link:

*Text messaging rates may apply.

 Dow Down0.16% Nasdaq Up0.40%

More On CUR.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


DiagnoCure Inc. (CUR.TO)

-Toronto
0.14 Down 0.01(3.33%) Jul 23
ProfileGet Profile for:
DiagnoCure Inc.
4535 Wilfrid-Hamel Boulevard
Suite 250
Quebec, QC G1P 2J7
Canada - Map
Phone: 418-527-6100
Fax: 418-527-0240
Website: http://www.diagnocure.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:11

Business Summary 

DiagnoCure Inc., a life sciences company, develops and commercializes cancer diagnostic tests for the detection and management of cancer. The company primarily focuses on molecular diagnostic tests. It offers PCA3 test for the diagnosis of prostate cancer; and GCC marker, Previstage GCC staging test, GCC monitoring blood test, Shc proteins, and scientific publications for use in colorectal cancer management. The company was founded in 1994 and is headquartered in Quebec, Canada.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on DiagnoCure Inc.

Key Executives 
 PayExercised
Dr. Yves Fradet M.D., F.R.C.S., 63
Co-Founder, Chairman, Chief Exec. Officer, Pres and Chief Medical Officer
180.00K0.00
Mr. Fr Boivin ,
Interim Chief Financial Officer and Sr. Director of Fin. & Admin.
139.00K0.00
Ms. Danielle Allard M.Sc.,
Sr. Director of Corp. Affairs and Corp. Sec.
N/AN/A
Mr. Pierre Lapalme , 73
Advisor To The Pres
N/AN/A
Mr. Pierre D MBA,
Consulting Advisor to the Pres
N/AN/A
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in CAD.